Brief: Seastar Medical Announces FDA Approval Of Reduction In Mandatory Enrollment
02/12/2025 13:28
Dec 2 (Reuters) - SeaStar Medical Holding Corp ICU.O: SEASTAR MEDICAL ANNOUNCES FDA APPROVAL OF REDUCTION IN MANDATORY ENROLLMENT FOR SAVE SURVEILLANCE REGISTRY EVALUATING QUELIMMUNE™ SAFETY FOR PEDIATRIC AKI Source text: ID:nGNX5m34Nt Further company coverage: ICU.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on SeaStar Medical Holding
See all newsBrief: FDA Grants Seastar Medical Breakthrough Device Designation For Its Scd Therapy For The Treatment Of Hyperinflammation In Adult Patients With Sepsis Or A Septic Condition
SeaStar Medical Holding Corp reports results for the quarter ended June 30 - Earnings Summary
SeaStar Medical Q2 revenue jumps 82% on QUELIMMUNE demand
Brief: SeaStar Medical Q2 EPS USD -0.91
SeaStar Medical Holding Corp expected to post a loss of 97 cents a share - Earnings Preview